4//SEC Filing
Wrighton-Smith Peter 4
Accession 0001437749-19-019043
CIK 0001586049other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:00 PM ET
Size
7.1 KB
Accession
0001437749-19-019043
Insider Transaction Report
Form 4
Wrighton-Smith Peter
DirectorChief Executive Officer
Transactions
- Sale
Ordinary Shares
2019-09-23$14.92/sh−20,000$298,366→ 404,538 total - Sale
Ordinary Shares
2019-09-24$17.01/sh−80,000$1,361,096→ 324,538 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended.
- [F2]The price reported for the sales on September 23, 2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.87 to $14.95 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]The price reported for the sales on September 24, 2019 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.87 to $17.43 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
Documents
Issuer
Oxford Immunotec Global PLC
CIK 0001586049
Entity typeother
Related Parties
1- filerCIK 0001592286
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:00 PM ET
- Size
- 7.1 KB